PS
WST icon

Planning Strategies’s West Pharmaceutical WST Stock Holding History

Planning Strategies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718 Buy
+2
New +$611 ﹤0.01% 797

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Planning Strategies's WST Position: Q2 2026 in Review

Planning Strategies opened a new position in West Pharmaceutical (WST) in Q2 2026: 2 shares worth $718. The stake represents ﹤0.01% of the portfolio and ranks #797 among its holdings.

785 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Planning Strategies held 2 shares of West Pharmaceutical worth $718 as of Q2 2026.
  • West Pharmaceutical was a new Planning Strategies position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Planning Strategies's portfolio in Q2 2026, its #797 holding.
  • 785 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Planning Strategies's 13F filing for Q2 2026, filed 27 Jul 2026.